Tioga Research supports the research and early development (“R&eD”) of skin-applied formulations, including topical & transdermal drugs, and prestige cosmetic & beauty care products. We have particular strengths in formulation innovation and skin permeation screening. A contract research organization (“CRO”), we deliver R&D services to pharmaceutical, biotechnology, personal & beauty care clients worldwide.
Tioga Research is a ‘pure play’ CRO. We do not pursue our own end formulation products; every formulation product program we undertake is with an external sponsor or partner.
Tioga Research formally commenced operations in February 2011. The history of Tioga Research, though, dates to July 2002, when the predecessor company fqubed, Inc. ("fqubed") was formed. fqubed was acquired by Toronto-based Nuvo Research, Inc. ("Nuvo") in December 2005. Continuing operations as fqubed, Inc. until a formal name change to Nuvo Research US in 2010, fqubed was the research & development division of Nuvo until January 2011. Tioga Research was then created under a management buyout (“MBO”) in February 2011. After a period of substantial growth and expansion, Tioga Research became a wholly-owned subsidiary of Encube Ethicals in December, 2019.
